Tornar a notícies
Two ICREA spin offs obtain funding from H2020 SME support instrument. The entrepreneurs Laura Soucek (ICREA at VHIO) and Roger Gomis (ICREA at IRB) have both secured a bunch of money from H2020 SME instrument this week. Their two companies are attacking different aspects of cancer tumors. Inbiomotion, Roger’s company is testing a platform to prevent breast cancer from invading bone marrow. Peptomyc, Laura’s company, has invented an innovative mollecule that blocks one of the most critical oncogenes, applicable to a wide array of different tumors.
Congratulations Laura and Roger, and keep up the good work!
More details? Click here.
OTHER NEWS
La nit de la Recerca
Científics i científiques d'arreu de Catalunya comparteixen la seva feina amb xerrades, tallers, demostracions i jocs per a totes les…
ERC Public Engagement with Research Awards 2026
El Professor d’Investigació ICREA Karim Lekadir, de la Universitat de Barcelona, ha estat reconegut amb un dels ERC Public Engagement…
